On Friday, Altimmune Inc (NASDAQ: ALT) opened lower -1.13% from the last session, before settling in for the closing price of $7.06. Price fluctuations for ALT have ranged from $5.28 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 154.97% annually for the last half of the decade. Company’s average yearly earnings per share was noted 18.37% at the time writing. With a float of $70.53 million, this company’s outstanding shares have now reached $71.12 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -3857.69%, operating margin of -191365.38%, and the pretax margin is -199076.92%.
Altimmune Inc (ALT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 0.84%, while institutional ownership is 56.05%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.35% during the next five years compared to 35.74% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 16.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9929.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.73 million. That was inferior than the volume of 2.33 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.88%. Additionally, its Average True Range was 0.50.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 21.13%, which indicates a significant decrease from 48.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.93% in the past 14 days, which was lower than the 79.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.97, while its 200-day Moving Average is $7.18. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $7.30. Second resistance stands at $7.62. The third major resistance level sits at $7.82. If the price goes on to break the first support level at $6.78, it is likely to go to the next support level at $6.58. Assuming the price breaks the second support level, the third support level stands at $6.26.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 71,125K shares outstanding in the company with a market cap of 496.45 million. Presently, the company’s annual sales total 430 K according to its annual income of -88,450 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -22,850 K.
